INSURANCE

Exela Expands PCH Global Solution with Leading Healthcare Insurer

Exela Technologies | January 12, 2022

Exela Technologies, Inc. (“Exela”) today announced that it continues to expand its relationship with a leading health insurance organization that spans almost two decades. This customer continues to accelerate deployment of Exela’s PCH Global platform to speed up their digital transformation and improve both the member and provider experience. The latest expansion is valued at $6.2 million of additional contract value revenue.

Exela continues to invest in expanding PCH Global’s capabilities to provide a cloud hosted solution with one of the best edit resolutions for healthcare claims. This extension of deployment marks another milestone in the value proposition of the PCH Global platform to digitally connect members, providers and insurance companies to enable clean claims, payment transparency and digital appeals. PCH Global’s cloud network also offers increased scalability, the highest uptime and best business continuity protections. PCH Global has robust data analytics which are continually improving as Exela processes more and more data. Additionally, PCH Global’s improved data analytics can be accessed via a self-service model.

“We are proud of our long standing partnership and privileged to be part of customer’s digital transformation journey. Adoption of our PCH Global platform continues to address healthcare industry’s goal to deliver most efficient, cost effective and best healthcare to the members.”

Suresh Yannamani, President of Exela

About Exela Technologies

Exela Technologies is a business process automation (BPA) leader, leveraging a global footprint and proprietary technology to provide digital transformation solutions enhancing quality, productivity, and end-user experience. With decades of experience operating mission-critical processes, Exela serves a growing roster of more than 4,000 customers throughout 50 countries, including over 60% of the Fortune® 100. Utilizing foundational technologies spanning information management, workflow automation, and integrated communications, Exela’s software and services include multi-industry, departmental solution suites addressing finance and accounting, human capital management, and legal management, as well as industry-specific solutions for banking, healthcare, insurance, and the public sector. Through cloud-enabled platforms, built on a configurable stack of automation modules, and over 17,500 employees operating in 23 countries, Exela rapidly deploys integrated technology and operations as an end-to-end digital journey partner.

Spotlight

Total healthcare spending is expected to rise to one-fifth of the U.S. economy by 2025, according to a new infographic by the Peterson Center on Healthcare. The infographic drills down on U.S. healthcare spending trends as well as the impact of unnecessary and ineffective spending.

Spotlight

Total healthcare spending is expected to rise to one-fifth of the U.S. economy by 2025, according to a new infographic by the Peterson Center on Healthcare. The infographic drills down on U.S. healthcare spending trends as well as the impact of unnecessary and ineffective spending.

Related News

HEALTH TECHNOLOGY

HandsFree Health, a Voice-Enabled Healthcare Technology Platform, Joins The Microsoft For Startups Program

HandsFree Health | June 04, 2021

HandsFree Health™, provider of WellBe®, a secure, HIPAA compliant, voice-enabled virtual health assistant platform, has been selected to join the Microsoft for Startups program to help further develop its proprietary HIPAA compliant voice platform for healthcare. Microsoft for Startups is a global program that helps startups scale. As a member of the program, HandsFree Health will gain access to Microsoft's technologies, including Azure, as well as a streamlined path to selling alongside Microsoft and its global partner ecosystem. Microsoft and HandsFree Health worked together during the 2019 BUILD conference where HandsFree Health demonstrated the ability to integrate Azure Custom Vision with its HIPAA compliant platform to make prescription entry as easy as taking a picture. In collaboration with Microsoft, HandsFree Health will further develop their remote patient monitoring capabilities, advance their HIPAA compliant AI driven health content, and work towards integration with electronic medical records (EMR's). "It is an honor to have been selected to join the Microsoft for Startups program," said Dan Messina, President of HandsFree Health. "We often refer to the home as the 'front door' of healthcare, and this partnership will allow us to advance our platform to further enhance the patient experience in the home." HandsFree Health's HIPAA compliant platform leverages Microsoft technologies to provide a completely integrated approach to healthcare. The voice-enabled platform provides patients, members, and residents with access to information about their healthcare, call their doctor, receive health answers, upload reading from hundreds of connected medical devices and control their home environment using just their voice. "HandsFree Health's unique approach to in-home healthcare represents the type of company we want to align with as part of our startup program," said Sally Frank, WW Lead, Health & Life Sciences, Microsoft for Startups. "Their use of AI and voice technology on a HIPAA compliant platform has the potential to provide more efficient care and reduce re-admission rates, we look forward to playing a role in their continued success."

Read More

FUTURE OF HEALTHCARE

Microsofts Authparency for Startups to Remove Contact from the Earlier Approval Process and Wipeout Obstructions to Medical Care

OncoSpark | April 18, 2022

Authparency, an effort of OncoSpark Inc., a leader in value-based technology-enabled services, is focused on automating and improving the prior authorization process. Authparency, which is based on more than a decade of clinical and administrative prior authorization information, has been selected for the Microsoft for Startups Founders Hub, which will allow it to continue to develop and use its technology. The platform was designed with features and modules that take advantage of subject matter experts and interoperability for medical procedures as well as medications and infusions. Microsoft for Startups offers together with the technology, direction, and support we need to continue to have a strategic and fundamental impact on the value of patients and healthcare receipts. "This initiative serves as the foundational catalyst that is needed to harness confidence and speed in our solution, which is critical for patients and providers as we design less restrictive value-based therapeutic pathways," stated Jordan Johnson, Chief Innovation Officer of OncoSpark. Authparency was developed with the help of more than 100 doctors, patient advocates, benefit navigators, and other stakeholders who see the importance of greater patient, payer, and provider alignment. The platform's data is affecting pharma, industry, and health policy in terms of openness and access to care, as well as aiding clinical decision-making. "The onerous prior authorization requirements burden practices with a variety of barriers, including issues submitting documentation through disparate health plan web portals. This remains a major problem in healthcare as we are seeing an increase in those seeking specialty care and an even greater increase in barriers to this care. By standardizing the process and creating relational data, we are able to work directly with payers and pharmaceutical companies to drive optimization and value." Manish Jain, a co-founder of OncoSpark Jordan Johnson added, "The commitment and values of the Microsoft and Oncospark teams allow us to serve communities, patients, and providers to reduce barriers in a dynamic and changing environment." Bringing tracking, payer connectivity, direct submission, insurance validation, HUB enrollment, and assistance pathways into one integrated platform ensures viability, sustainability, and optimal resource allocation for providers and practices that operate on razor-thin margins and struggle with staffing.

Read More

FUTURE OF HEALTHCARE

Exact Sciences Acquires PreventionGenetics to Accelerate Availability of Hereditary Cancer Testing for More Patients

Exact Sciences Corp. | January 10, 2022

Exact Sciences Corp.announced today it has acquired PreventionGenetics, a genetic testing laboratory, to complement its advanced cancer diagnostics portfolio and support its entrance into hereditary cancer testing (HCT). PreventionGenetics provides the clinical lab, expertise, and foundational technology necessary to accelerate the availability of HCT and help more patients know their germline risk of cancer and other diseases. "PreventionGenetics is a natural fit with Exact Sciences, and we're thrilled to have their talented team join in our mission to make earlier cancer detection a routine part of medical care. We share in PreventionGenetics' belief that genetics can transform medicine, improve lives, and help eradicate cancer. With our deep relationships in primary care and PreventionGenetics' strong reputation among genetics specialists, Exact Sciences can help more people understand their inherited risk of cancer to catch it earlier and treat it more effectively." Kevin Conroy, Exact Sciences chairman and CEO Nearly 300,000 health care providers and more than 200 large U.S. health systems rely on Exact Sciences' Cologuard® and Oncotype DX® tests in primary care, women's health, oncology, and other specialties. In partnership with the PreventionGenetics team, Exact Sciences plans to leverage its unmatched commercial reach in diagnostics to expand hereditary cancer and genetic testing throughout the U.S. and globally. PreventionGenetics is a CLIA-certified and CAP-accredited clinical DNA testing laboratory, providing more than 5,000 predefined genetic tests for nearly all clinically relevant genes, additional custom panels, and comprehensive germline whole exome and whole genome sequencing tests. With a goal to improve lives through genetic testing, PreventionGenetics offers tests spanning decades of life including proactive health and wellness, cancer risk and screening, pediatric and adult-onset rare diseases, and others. These high-quality genetic tests are supported by deep sequencing capabilities and more than 100 peer-reviewed publications. Like Exact Sciences, the PreventionGenetics team is relentless in their pursuit of quality. This focus, combined with a best-in-class customer experience and turnaround times, has earned PreventionGenetics a strong reputation and brand recognition among genetics specialists and counselors. About PreventionGenetics Founded in 2004 and located in Marshfield, Wisconsin, PreventionGenetics is a CLIA and ISO 15189:2012 accredited laboratory. PreventionGenetics delivers clinical genetic testing of the highest quality at fair prices with exemplary service to people around the world. PreventionGenetics has 25 PhD geneticists on staff and provides tests for nearly all clinically relevant genes including the powerful and comprehensive germline whole genome sequencing test, PGnome® and whole exome sequencing test, PGxome®. About Exact Sciences Corp. A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer.

Read More